T he American-European consensus conference (AECC) criteria for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) include the acute onset of: 1) bilateral infiltrates on frontal chest radiograph, 2) PaO 2 /FIO 2 less than or equal to 300 Torr (ALI) or 200 Torr (ARDS), and 3) absence of clinical indicators of left atrial hypertension (1) . Many clinical studies of ALI/ARDS have used the AECC criteria to identify potentially eligible patients (2) (3) (4) (5) (6) (7) (8) .
In some patients with bilateral infiltrates, PaO 2 /FIO 2 ratios were lower than 200 while they received mechanical ventilation with zero or low levels of positive end-expiratory pressure (PEEP), but PaO 2 /FIO 2 ratios then increased to Ͼ200 or even 300 when low to moderate levels of PEEP were subsequently applied (9 -12) . In these patients, atelectasis could have been an important cause of hypoxemia rather than shunt from consolidation and pulmonary edema. In one study, the mortality of these patients was considerably lower than those whose PaO 2 / FIO 2 ratios remained below 200 after raising PEEP (10) . Furthermore, in many patients with bilateral infiltrates, PaO 2 / FIO 2 increased substantially when FIO 2 levels were raised from moderate to high levels (11, 13) . This suggests that among patients with similar PaO 2 /FIO 2 ratios, oxygenation failure is worse and risk of death is higher in those receiving higher FIO 2 levels. Thus, without standardized or minimum PEEP and FIO 2 criteria, the AECC criteria could identify a heterogeneous group of patients, some of whom are at low risk of adverse outcomes such Objectives: The criteria that define acute lung injury and the acute respiratory distress syndrome include PaO 2 /FIO 2 but not positive end-expiratory pressure or FIO 2 . PaO 2 /FIO 2 ratios of some patients increase substantially after mechanical ventilation with positive end-expiratory pressure of 5-10 cm H 2 O, and the mortality of these patients may be lower than those whose PaO 2 /FIO 2 ratios remain <200. Also, PaO 2 /FIO 2 may increase when FIO 2 is raised from moderate to high levels, suggesting that patients with similar PaO 2 /FIO 2 ratios but different FIO 2 levels have different risks of mortality. The primary purpose of this study was to assess the value of adding baseline positive end-expiratory pressure and FIO 2 to PaO 2 /FIO 2 for predicting mortality of acute lung injury/acute respiratory distress syndrome patients enrolled in Acute Respiratory Distress Syndrome Network clinical trials. We also assessed effects of two study interventions on clinical outcomes in subsets of patients with mild and severe hypoxemia as defined by PaO 2 /FIO 2 .
Design: Analysis of baseline physiologic data and outcomes of patients previously enrolled in clinical trials conducted by the National Institutes of Health Acute Respiratory Distress Syndrome Network.
Setting: Intensive care units of 40 hospitals in North America. Patients: Two thousand three hundred and twelve patients with acute lung injury/acute respiratory distress syndrome.
Interventions: None.
Measurements and Main Results: Only 1.3% of patients enrolled in Acute Respiratory Distress Syndrome Network trials had baseline positive end-expiratory pressure <5 cm H 2 O, and 50% had baseline positive end-expiratory pressure >10 cm H 2 O. Baseline PaO 2 /FIO 2 predicted mortality, but after controlling for PaO 2 / FIO 2 , baseline positive end-expiratory pressure did not predict mortality. In contrast, after controlling for baseline PaO 2 /FIO 2 , baseline FIO 2 did predict mortality. Effects of two study interventions (lower tidal volumes and fluid-conservative hemodynamic management) were similar in mild and severe hypoxemia subsets as defined by PaO 2 /FIO 2 ratios.
Conclusion: At Acute Respiratory Distress Syndrome Network hospitals, the addition of baseline positive end-expiratory pressure would not have increased the value of PaO 2 /FIO 2 for predicting mortality of acute lung injury/acute respiratory distress syndrome patients. In contrast, the addition of baseline FIO 2 to PaO 2 / FIO 2 could be used to identify subsets of patients with low or high mortality. (Crit Care Med 2011; 39:2025-2030) KEY WORDS: acute lung injury; clinical trials; mechanical; positive end-expiratory pressure; randomized; ventilation as death. If so, then use of the AECC criteria to identify patients for ALI/ARDS trials, without PEEP and FIO 2 criteria, could reduce the power of clinical trials because potential effects of new interventions may be smaller in patients with mild disease. Some investigators have speculated that the results of trials that enrolled ALI/ARDS patients using the AECC criteria without a minimum PEEP level were confounded by imbalances between study groups in patients with mild and severe lung injury that could not be detected without increasing PEEP (10) . The National Institutes of Health ARDS Network has used the AECC criteria as the inclusion criteria for most of its clinical trials since 1996 (2-5, 14, 15) . Exclusion criteria reduced heterogeneity of the enrolled populations, but patients were not excluded if they were on zero or low PEEPs or low FIO 2 levels. The primary purpose of the present study was to explore the potential value of adding PEEP and FIO 2 criteria to the AECC criteria to exclude patients with low risk of mortality. A secondary purpose was to address the concern that in patients with mild disease, potential effects of an intervention may be small or nonexistent. To address this concern, we examined effects of two study interventions on subsets of ALI/ARDS patients with mild and severe hypoxemia. Parts of this study were presented previously in abstracts (16, 17) .
MATERIALS AND METHODS
We reviewed existing data from 2,443 patients enrolled in four ARDS Network clinical trials from 1996 to 2005 (Table 1) (2-5). Etiological causes of ALI/ARDS were listed as pneumonia (41%), sepsis (24%), aspiration (15%), trauma (9%), and other causes (11%).
Baseline ventilator settings were set by clinicians and were available within 4 hrs before the time of randomization. Baseline values usually occurred several or many hours after the criteria for ALI were initially met.
We created a frequency distribution of baseline PEEP levels. To characterize the relationship between baseline PEEP and FIO 2 , we divided baseline FIO 2 into ten subsets, each with FIO 2 range of 0.10, and then displayed distributions of PEEP within each interval. We calculated a correlation coefficient and corresponding 95% confidence interval to assess the relationship between baseline PEEP and FIO 2 .
We created tertiles of PaO 2 /FIO 2 , each containing approximately 770 patients. We used Cochrane-Armitage trend tests to determine whether PaO 2 /FIO 2 tertiles predicted mortality. We created three groups of baseline PEEP (Յ5, 6 -10, and Ն11 cm H 2 O) and baseline FIO 2 (Յ0.50, 0.50 -0.69, and Ն0.70) within each PaO 2 /FIO 2 tertile. We used Cochrane-Armitage trend tests to determine whether differences in PEEP and FIO 2 within each PaO 2 /FIO 2 tertile were associated with differences in mortality.
Oxygenation index (OI) combines mean airway pressure (mPaw) with PaO 2 /FIO 2 : OI ϭ mPaw ϫ 100 ϫ FIO 2 /PaO 2 . Many studies suggest that OI is useful to assess severity of oxygenation failure and risk of death in individual ALI patients (18 -20) . To compare the value of PaO 2 /FIO 2 and OI for predicting mortality, we calculated areas under the curve for receiver operating characteristics for both PaO 2 /FIO 2 and OI.
In previous studies, mechanical ventilation with lower tidal volumes reduced mortality (2) , and a fluid-conservative hemodynamic strategy was associated with greater ventilator-free days (4) . To test the hypothesis that the effects of these interventions were greater in patients with more severe illness, we compared the effects of the interventions in pa-tients with mild and severe baseline hypoxemia. First, we ranked patients in the tidal volume and hemodynamic strategy trials according to baseline PaO 2 /FIO 2 . We then divided the patients in each trial into baseline PaO 2 / FIO 2 quartiles. Patients with mild and severe hypoxemia were defined as those in the highest and lowest PaO 2 /FIO 2 quartiles, respectively. We compared the effects of study interventions in the highest and lowest PaO 2 /FIO 2 quartiles.
In the ARDS Network trial of higher vs. lower PEEP (3), patients in the higher PEEP study group received PEEPs of at least 12 cm H 2 O after randomization. To assess effects of approximately 12-18 hrs of mechanical ventilation with these higher PEEP levels, we compared frequency distributions of PaO 2 /FIO 2 at baseline and on day 1 after randomization. We calculated mortality rates for patients with PaO 2 /FIO 2 ratios Ͻ200, 201-300, and Ͼ300 on the day after randomization. Patients or their surrogates gave informed consent for the original clinical trials. The institutional review board of Johns Hopkins Medicine approved this study of existing data with a waiver of the requirement for informed consent.
RESULTS
Complete physiologic and outcome data were available on 2,312 patients enrolled in the four clinical trials. Of these, 77% had PaO 2 /FIO 2 Յ200; mortality in this group was 31.4%. Of the remaining 23% with PaO 2 /FIO 2 Ͼ200, mortality was 21.9% (p Ͻ .0001 for the comparison of mortalities).
The distribution of baseline PEEPs for all subjects is shown in Figure 1 . The most frequently used baseline PEEPs were 5 and 10 cm H 2 O. Very few patients (1.3%) had baseline PEEPs Ͻ5 cm H 2 O. Approximately 50% of all patients had baseline PEEPs of 10 cm H 2 O or greater.
The relationship between the clinician-set baseline PEEP and FIO 2 levels is shown in Figure 2 . Most clinicians selected PEEPs of 5, 8, or 10 cm H 2 O. When FIO 2 was 50% or less, most clinicians selected either 5 or 8 cm H 2 O. When FIO 2 was above 50%, most clinicians selected 10 cm H 2 O. There was substantial variability in how baseline PEEPs and FIO 2 s were combined. However, there were relatively few patients with high baseline PEEP combined with low baseline FIO 2 . Levels of baseline PEEP and FIO 2 were positively and significantly correlated ( ϭ .47, 95% confidence interval 0.42 to 0.51; p Ͻ .001). Thus, although individual approaches varied, clinicians as a a Baseline PaO 2 /FIO 2 and positive end-expiratory pressure values (Ϯ SD) are for all patients enrolled in the trials; b 904 includes 861 patients randomized to traditional or lower tidal volumes and 43 patients who, after the tidal volume trial completed enrollment, were assigned to the lower tidal volume protocol during continued enrollment in another trial that had been combined with the tidal volume trial in a factorial design (14) ; c two trials were conducted together in a factorial design in the same patients.
whole had apparently adjusted PEEP and FIO 2 in concert.
In univariate analyses, lower baseline PaO 2 /FIO 2 predicted 60 day mortality (Table 2). Higher baseline PEEP levels also predicted higher 60 day mortality. Within each PEEP range (Յ5, 6 -10, Ͼ10 cm H 2 O) mortality increased with decreasing PaO 2 /FIO 2 (Table 2 ). However, within each PaO 2 /FIO 2 tertile, mortality did not increase significantly with increasing PEEP. Like higher PEEP, higher FIO 2 also predicted higher 60 day mortality (Table  3 ). However, unlike higher PEEP, within each PaO 2 /FIO 2 tertile, mortality increased significantly with increasing FIO 2 .
The areas under the curve of the receiver operating characteristics for OI and PaO 2 /FIO 2 were 0.58 and 0.57, respectively. Thus, the addition of mPaw to PaO 2 /FIO 2 did not improve mortality prediction.
We next compared the effects of the lower tidal volume and fluid-conservative hemodynamic management strategies on patients in the mildest and most severe quartiles of baseline hypoxemia as defined by PaO 2 /FIO 2 . Effects of tidal volume reduction on mortality were similar in the mild and severe hypoxemia quartiles of the tidal volume trial (Fig. 3 ). The interaction between study group and hypoxemia quartile was not significant (p ϭ .814). Also, the interaction between study group and FIO 2 quartiles was not significant (p ϭ .259). The effect of fluid-conservative management on ventilator-free days was similar in the mild and severe hypoxemia quartiles of the hemodynamic management trial (Fig. 4 ). The interaction between study group and hypoxemia subset was not significant (p ϭ .106).
Frequency distributions of PaO 2 /FIO 2 at baseline and on the first day after enrollment in the higher PEEP and lower PEEP study groups of the ARDS Network PEEP trial are shown in Figure 5 . The proportions of patients in the higher PEEP group with baseline PaO 2 /FIO 2 Ͻ200, 201-300, and Ͼ300 were 79%, 17%, and 4%, respectively. After approximately 12-18 hrs of ventilation with PEEPs of at least 12 cm H 2 O in the higher PEEP group, these proportions shifted to 50%, 36%, and 14%, respectively. The mortality rates of these groups, categorized according to PaO 2 / FIO 2 after 12-18 hrs of mechanical ventilation with higher PEEP, were 31%, 28%, and 13.5%, respectively.
DISCUSSION
The AECC criteria were designed to identify a large group of patients who could be of concern to investigators and clinicians because of ALI or ARDS (1). Because these criteria are inclusive, the resulting population may be very heterogeneous in disease severity and clinical outcomes. Therefore, most clinical trials exclude many patients who meet the AECC criteria to reduce heterogeneity in the enrolled cohorts. ARDS Network trials did not exclude patients who had received zero or very low-level PEEPs at baseline. However, only 1.3% of patients enrolled in ARDS Network trials had baseline PEEP levels Ͻ5 cm H 2 O, and approximately 50% of patients had baseline PEEPs of 10 cm H 2 O or more. Baseline PEEP alone predicted mortality, but after controlling for baseline PaO 2 /FIO 2 , PEEP did not predict mortality (Table 2 ). Furthermore, effects of two effective study interventions were similar in quartiles of patients defined by the highest and lowest PaO 2 /FIO 2 ratios, without knowledge of baseline PEEP. These results suggest that at ARDS Network hospitals, addition of a minimum level of PEEP to the PaO 2 /FIO 2 ratio would not have improved the ability to identify patients at higher risk of death or patients more or less likely to benefit from a new intervention. However, substantial proportions of patients received PEEPs of Ͻ5 cm H 2 O in some other studies of mechanically ventilated patients. Some of these could have had mild ALI/ARDS with low mortality rates (21) (22) (23) . To avoid enrolling these patients in clinical trials, a minimum PEEP of 5 cm H 2 O could be required in the eligibility criteria.
In previous studies of ALI/ARDS, some patients with PaO 2 /FIO 2 Յ200 had PaO 2 / FIO 2 s that were Ͼ200 or even 300 after mechanical ventilation with PEEPs of 5-10 cm H 2 O or greater (9 -12) . In three of these studies, the mortality rates of the patients with higher PaO 2 /FIO 2 ratios after ventilation with PEEP were substantially lower than those whose PaO 2 /FIO 2 ratios remained below 200 (9 -11) . For example, in one of the previous studies, patients were ventilated for 24 hrs with PEEP of at least 10 cm H 2 O before categorizing by PaO 2 /FIO 2 . Mortality rates for cohorts with PaO 2 /FIO 2 Ͻ200, 201-300, and Ͼ300 were 45.5%, 20%, and 6.3%, respectively (10) . However, some of the patients included in these studies had received PEEPs of Ͻ5 cm H 2 O before the standardized ventilator settings. In contrast, only 1% of patients enrolled in ARDS Network trials had received PEEPs of Ͻ5 cm H 2 O before enrollment. Furthermore, patients enrolled in the ARDS Network studies had received mechanical ventilation for at least several hours and frequently for Ͼ24 hrs before the baseline AECC data were recorded. Thus, the baseline ventilator settings and arterial oxygenation of the patients enrolled in ARDS Network trials may have been more similar to those of the patients in the previous studies after ventilation with standardized PEEP than to the initial measurements recorded in the previous studies before ventilation with standardized PEEP.
In single variable analyses, baseline PEEP and baseline PaO 2 /FIO 2 both predicted mortality. However, some clinicians had apparently used higher PEEP in conjunction with higher FIO 2 (or lower PEEP with lower FIO 2 ), presumably to achieve arterial oxygenation goals (Fig. 2) . Therefore, baseline PaO 2 /FIO 2 conferred additional information about baseline PEEP. After controlling for baseline PaO 2 /FIO 2 , the addition of baseline PEEP did not predict mortality. Furthermore, the addition of mPaw to PaO 2 /FIO 2 (in the OI) did not increase the predictive value of PaO 2 /FIO 2 . Clinicians' manipulations of PEEP probably caused similar changes in mPaw.
The ARDS Network trials also did not use FIO 2 , independent of PaO 2 /FIO 2 , to exclude patients at low risk of adverse outcomes. In contrast to the findings with PEEP, FIO 2 did predict mortality after controlling for PaO 2 /FIO 2 . However, in each of the PaO 2 /FIO 2 tertiles, the range of mortality between the lowest and highest FIO 2 ranges was approximately 10%, and the lowest mortality (in the subset with the highest PaO 2 /FIO 2 and lowest FIO 2 ) was still substantial at 21%. A subset with substantially lower mortality (with even lower FIO 2 s and higher PaO 2 / FIO 2 s) could probably be identified, but this subset would be quite small.
Our results and interpretations are from analyses of the cohorts of patients enrolled in the trials, which includes patients with several etiological causes of ALI. Effects of PEEP may be different in groups of patients with direct vs. indirect lung injury (24) . If so, then PEEP could add to the predictive value of PaO 2 /FIO 2 in one of these subsets but not the other. However, more recent studies did not demonstrate different effects of PEEP in direct vs. indirect lung injury (3, 25) .
In this study, mortality was lower in patients whose PaO 2 /FIO 2 ratios were Ͼ200 than in those whose PaO 2 /FIO 2 ratios were lower than 200. The difference in mortality was similar to but not as marked as in the previous studies (9 -11) in which patients received standardized ventilator settings with 5-10 cm H 2 O PEEP for up to 24 hrs before determination of PaO 2 /FIO 2 . This difference between our study and the previous studies may be attributable to higher levels of PEEP received by some patients in our study at baseline than in the previous studies before patients received standardized ventilator settings for up to 24 hrs. Patients with PaO 2 /FIO 2 ratios Ͼ300 at the time of screening were not eligible for enrollment in ARDS Network trials, and their PaO 2 /FIO 2 ratios and ventilator settings would not be available in our dataset.
Eligibility criteria for clinical trials are frequently designed to avoid enrollment of patients who are unlikely to benefit from a new study intervention, such as those with very low mortality rates, especially if the intervention carries substantial risk. Mortality was significantly lower in patients with higher PaO 2 /FIO 2 ratios in our cohort (Table 2 ). However, the effects of lower tidal volume and fluidconservative hemodynamic management were similar among groups of patients with very low and high baseline PaO 2 /FIO 2 ratios. Thus, inclusion of patients with mild hypoxemia at baseline did not diminish the power of the trials. On the other hand, by including patients with higher PaO 2 /FIO 2 ratios, the trial results are applicable to a greater proportion of ALI/ARDS patients. Perhaps we could identify a subset with milder impairment in arterial oxygenation in which mortality was even lower; the effects of useful interventions could be less or absent in this subset. However, this subset would probably be small.
In two previous trials in ARDS patients, new therapeutic interventions appeared to be effective only in subsets of patients with severe disease (26, 27) . However, in the ARDS Network tidal volume and hemodynamic management trials, effects of the interventions were similar across the ranges of severity as defined by PaO 2 /FIO 2 . Thus, patients with mild and moderate ALI/ARDS, as defined by PaO 2 /FIO 2 , can benefit from some interventions that reduce mortality or time on mechanical ventilation. It is also possible that there is a level of severity above which outcomes are less modifiable by a new clinical trial intervention.
A strength of this study is the large number of patients with pertinent data and the large number of contributing hospitals and intensive care units. The data were collected during conduct of the ARDS Network trials, when patients were enrolled in clinical trials. Therefore, the data are relevant to the concerns raised regarding the lack of a minimum PEEP in the eligibility criteria of these trials. A limitation of this study is that while our conclusions apply to the specific trials conducted and to the ARDS Network hospitals where they were conducted, they may not apply in other circumstances. Clinicians' practices for setting PEEP and FIO 2 are highly variable (22, 28, 29) . It is possible that there is greater variability in how PEEP is used at other hospitals. Some clinicians prefer to use very low PEEP, even when FIO 2 has been raised to high levels. In such circumstances, a minimum PEEP criterion for eligibility in a clinical trial could help to avoid enrollment of patients with very mild disease. It is also possible that our analyses could not detect a small predictive value of baseline PEEP when added to baseline PaO 2 /FIO 2 for predicting mortality because of inadequate sample size. Finally, since many patients with ALI/ARDS were excluded from ARDS Network trials, our analysis may not be applicable to those who were not included.
